AUG 17, 2026 · JOURNAL ARTICLE
Therapies for Cardiovascular‐Kidney‐Liver‐Metabolic Syndrome: Reappraisal of Fibrates
Diabetes Obesity and Metabolism
A narrative review synthesizing existing clinical evidence and mechanistic pathways to reappraise fibrate therapy within a proposed disease framework, intended to inform clinical thinking rather than report new trial results.
Study details
DesignNarrative review
InterventionFibrates (primarily fenofibrate) and select…
ComparatorContemporary therapies including SGLT2i, GL…